| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma - Implications for therapeutics | Seubwai, W Wongkham, C Puapairoj, A Khuntikeo, N Wongkham, S |
2007 | ||||
| 2. | Vitamin D suppresses tumour growth and enhances cyto-toxicity of chemotherapeutic agents in cholangiocarcinoma | S. Woncikham W. Seubwail C. Wongkham A. Puapairoj S. Okada |
2008 | ||||
| 3. | 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma. | Seubwai, W Wongkham, C Puapairoj, A Okada, S Wongkham, S |
2010 | ||||
| 4. | 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculutre of cholangiocarcinoma | Wunchana Seubwai Chaisiri Wongkham Anucha Puapairoj Seiji Okada Sopit Wongkham |
2010 | ||||
| 5. | Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-kappa B | Seubwai, W. Vaeteewoottacharn, K. Puapairoj, A. Okada, S. Wongkham, S. |
2010 | ||||
| 6. | CEPHARANTHINE EXERTS ANTITUMOR ACTIVITY ON CHOLANGIOCARCINOMA BY INHIBITION OF NF-KB ACTION | W. Seubwai K. Vaeteewoottacharn A. Puapairoj C. Wongkham S. Okada S. Wongkham |
2011 | ||||
| 7. | Cepharanthine Suppresses Metastatic Potential of Human Cholangiocarcinoma Cell Lines | Uthaisar, K Seubwai, W Srikoon, P Vaeteewoottacharn, K Sawanyawisuth, K Okada, S Wongkham, S |
2012 | ||||
| 8. | Hypoxia enhances aggressiveness of Cholangiocarcinoma cells | Seubwai, W Kraiklang, R Wongkham, C Wongkham, S |
2012 | ||||
| 9. | Involvement of p53 and nuclear factor-kappaB signaling pathway for the induction of G1-phase cell cycle arrest of cholangiocarcinoma cell lines by isomorellin. | Chariya Hahnvajanawong Supaluk Ketnimit Kovit Pattanapanyasat Natthinee Anantachoke Banchob Sripa Khosit Pinmai Wunchana Seubwai Vichai Reutrakul |
2012 | ||||
| 10. | Natural Products for Prevention and Treatment of Cholangiocarcinoma | Chariya Hahnvajanawong Khon Kaen University - Natural Products Chemistry Research Unit Wunchana Seubwai Faculty of Medicine - Department of Forensic Medicine Thidarut Boonmars Faculty of Medicine - Department of Parasitology Kulthida Vaeteewoottacharn Faculty of Medicine - Department of Biochemistry |
2012 | ||||
| 11. | Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil. | Chariya Hahnvajanawong Jariya Chaiyagool Wunchana Seubwai Vajarabhongsa Bhudhisawasdi Nisana Namwat Narong Khuntikeo Banchob Sripa Ake Pugkhem Wichittra Tassaneeyakul |
2012 | ||||
| 12. | TNP-470, A Methionine Aminopeptidase-2 Inhibitor, Inhibits Cell Proliferation, Migration and Invasion of Human Cholangiocarcinoma Cells In Vitro | Kidoikhammouan, S Seubwai, W Tantapotinan, N Silsirivanit, A Wongkham, S Sawanyawisuth, K Wongkham, C |
2012 | ||||
| 13. | Determining the Manner of Death Using Fourier Transform Infrared Microspectroscopy: A Preliminary Study | Wunchana Seubwai Wirut Khunkitti Maneewan Tanratanavijit Thitichai Wiangsimma Molin Wongwattanakul Patcharee Jearanaikoon Sirinart Srichan |
2013 | ||||
| 14. | Enhanced antitumor activity of DHMEQ, a NF-κB Inhibitor, on Cholangiocarcinoma Cell Lines by Decreasing the Expression of ABC Transporters | Wunchana Seubwai Kulthida Vaeteewoottacharn Kazuo Umezawa Seiji Okada Sopit Wongkham |
2013 | ||||
| 15. | Establishment of an Allo-Transplantable Hamster Cholangiocarcinoma Cell Line and Its Application for In Vivo Screening of Anti-Cancer Drugs | Puthdee, N. Vaeteewoottacharn, K. Seubwai, W. Wonkchalee, O. Kaewkong, W. Juasook, A. Pinlaor, S. Pairojkul, C. Wongkham, C. Okada, S. Boonmars, T. Wongkham, S. |
2013 | ||||
| 16. | Aberrant expression of NF-κB in liver fluke associated cholangiocarcinoma: implications for targeted therapy. | Wunchana Seubwai Chaisiri Wongkham Anucha Puapairoj Narong Khuntikeo Ake Pugkhem Chariya Hahnvajanawong Jariya Chaiyagool Kazuo Umezawa Seiji Okada Sopit Wongkham |
2014 | ||||
| 17. | A NOVEL ANTICANCER ALKALOID TILIACORININE INDUCES SUSTAINED ACTIVATION OF THE EXTRACELLULAR SIGNAL-REGULATED KINASE AND SYNERGIZES WITH CISPLATIN IN CHOLANGIOCARCINOMA CELLS | S. Janeklang W. Seubwai K. Vaeteewoottacharn P. Boonsiri G. Kismali A. Nakaew A. Suksamrarn S. Okada S. Wongkham |
2014 | ||||
| 18. | Application of Molecular Biology Techniques on Forensic Sciences | Wunchana Seubwai Wirut Khunkitti |
2014 | ||||
| 19. | Association between cellular radiosensitivity and G1/G2 checkpoint proficiencies in human cholangiocarcinoma cell lines | Hematulin, A. Sagan, D.L. Sawanyawisuth, K. Seubwai, W. Wongkham, S. |
2014 | ||||
| 20. | Diabetogenic Glucose Enhances Aggressive Activities of Cholangiocarcinoma Cell Lines | Charupong Saengboonmee Wunchana Seubwai Sopit Wongkham |
2014 | ||||
| 21. | High expression of HIF-1α, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis. | Thongchot, S. Yongvanit, P. Loilome, W. Seubwai, W. Phunicom, K. Tassaneeyakul, W. Pairojkul, C. Promkotra, W. Techasen, A. Namwat, N. |
2014 | ||||
| 22. | In vitro and in vivo antitumor activity of tiliacorinine in human cholangiocarcinoma | Somkid Janeklang Archawin Nakaew Kulthida Vaeteewoottacharn Wunchana Seubwai Patcharee Boonsiri Gorkem Kismali Apichart Suksamrarn Seiji Okada Sopit Wongkham |
2014 | ||||
| 23. | Potential Glyco-Biomarkers Identified Suicide Victims | Wunchana Seubwai Wirut Khunkitti Maneewan Tanratanavijit Thitichai Wiangsimma Sopit Wongkham |
2014 | ||||
| 24. | Potential targeted therapy for liver fluke associated cholangiocarcinoma | Vaeteewoottacharn, K. Seubwai, W. Bhudhisawasdi, V. Okada, S. Wongkham, S. |
2014 | ||||
| 25. | Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma: Association of diabetes mellitus and cholangiocarcinoma. | Saengboonmee, C. Seubwai, W. Wongkham, C. Wongkham, S. |
2015 | ||||
| 26. | Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness | Wattanawongdon, W Hahnvajanawong, C Namwat, N Kanchanawat, S Boonmars, T Jearanaikoon, P Leelayuwat, C Techasen, A Seubwai, W |
2015 | ||||
| 27. | Improve discrimination power of serum markers for diagnosis of cholangiocarcinoma using data mining-based approach. | Sirorat Pattanapairoj Atit Silsirivanit Kanha Muisuk Wunchana Seubwai Ubon Cha'on Kulthida Vaeteewoottacharn Kanlayanee Sawanyawisuth Danaipong Chetchotsak Sopit Wongkham |
2015 | ||||
| 28. | Inhibition of NF-kappa B Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells | Wunchana Seubwai Kulthida Vaeteewoottacharn Ratthaphol Kraiklang Kazuo Umezawa Seiji Okada Sopit Wongkham |
2015 | ||||
| 29. | Synthesis of 5-fluorouracil nanoparticles and its inhibition of Cholangiocarcinoma in vitro | N. Ngernyuang W. Seubwai S. Daduang P. Boonsiri T. Limpaiboon J. Daduang |
2015 | ||||
| 30. | Tumor Glycolysis as a Target for Cancer Diagnosis and Therapy | Wunchana Seubwai | 2015 | ||||
| 31. | Establishment and characterization of a novel human cholangiocarcinoma cell line with high metastatic activity. | Uthaisar, K. Vaeteewoottacharn, K. Seubwai, W. Talabnin, C. Sawanyawisuth, K. Obchoei, S. Kraiklang, R. Okada, S. Wongkham, S. |
2016 | ||||
| 32. | High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation. | Charupong Saengboonmee Wunchana Seubwai Chawalit Pairojkul Sopit Wongkham |
2016 | ||||
| 33. | Inhibition of NF-κB activity enhances sensitivity to anticancer drugs in cholangiocarcinoma cells | Seubwai, W Vaeteewoottacharn, K Kraiklang, R Umezawa, K Okada, S Wongkham, S |
2016 | ||||
| 34. | Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-kappa B | Phoomak, C. Vaeteewoottacharn, K. Sawanyawisuth, K. Seubwai, W. Wongkham, C. Silsirivanit, A. Wongkham, S. |
2016 | ||||
| 35. | Overexpression of lactate dehydrogenase A in cholangiocarcinoma is correlated with poor prognosis. | Thonsri, U Seubwai, W Waraasawapati, S Sawanyawisuth, K Vaeteewoottacharn, K Boonmars, T Cha'on, U |
2016 | ||||
| 36. | Targeted delivery of 5-fluorouracil to cholangiocarcinoma cells using folic acid as a targeting agent | Ngernyuang, N Seubwai, W Daduang, S Boonsiri, P Limpaiboon, T Daduang, J |
2016 | ||||
| 37. | Berberine Induces Cell Cycle Arrest in Cholangiocarcinoma Cell Lines via Inhibition of NF-κB and STAT3 Pathways. | Puthdee, N. Seubwai, W. Vaeteewoottacharn, K. Boonmars, T. Cha'on, U. Phoomak, C. |
2017 | ||||
| 38. | High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation | Phoomak, C Vaeteewoottacharn, K Silsirivanit, A Saengboonmee, C Seubwai, W Sawanyawisuth, K Wongkham, C Wongkham, S |
2017 | ||||
| 39. | Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-ĸB. | Saengboonmee, C Seubwai, W Cha'on, U Sawanyawisuth, K Wongkham, S Wongkham, C |
2017 | ||||
| 40. | Metformin exerts antiproliferative and anti-metastatic effects against cholangiocarcinoma cells by targeting STAT3 and NF-κB | Charupong Saengboonmee Wunchana Seubwai Ubon Cha'on Kanlayanee Sawanyawisuth Sopit Wongkham Chaisiri Wongkham |
2017 | ||||
| 41. | Overexpression of lactate dehydrogenase A in cholangiocarcinoma is correlated with poor prognosis | Unchalee Thonsri Wunchana Seubwai Sakda Waraasawapati Kanlayanee Sawanyawisuth Kulthida Vaeteewoottacharn Thidarat Boonmars Ubon Cha'on |
2017 | ||||
| 42. | Targeting hexokinase II as a possible therapy for cholangiocarcinoma | Thamrongwaranggoon, U Seubwai, W Phoomak, C Sangkhamanon, S Cha'on, U Boonmars, T Wongkham, S |
2017 | ||||
| 43. | Upregulation of CD147 Promotes Metastasis of Cholangiocarcinoma by Modulating the Epithelial-to-Mesenchymal Transitional Process. | Paweena Dana Ryusho Kariya Kulthida Vaeteewoottacharn Kanlayanee Sawanyawisuth Wunchana Seubwai Kouki Matsuda Seiji Okada Sopit Wongkham |
2017 | ||||
| 44. | Activation of Vimentin Is Critical to Promote a Metastatic Potential of Cholangiocarcinoma Cells | Saentaweesuk, W Araki, N Vaeteewoottacharn, K Silsirivanit, A Seubwai, W Talabnin, C Muisuk, K Sripa, B Wongkham, S Okada, S Wongkham, C |
2018 | ||||
| 45. | ANTI-MALARIAL DRUGS ARTESUNATE AND CHLOROQUINE INDUCE CELL DEATH BY DIFFERENT MECHANISMS IN BILE DUCT CANCER CELL LINES | Diwakar Guragain Norie Araki Atit Silsinivanit Wunchana Seubwai Ubon Cha'on |
2018 | ||||
| 46. | Artesunate and chloroquine induce cytotoxic activity on cholangiocarcinoma cells via different cell death mechanisms | Guragain, D Seubwai, W Kobayashi, D Silsinivanit, A Vaeteewoottacharn, K Sawanyawisuth, K Wongkham, C Wongkham, S Araki, N Cha'on, U |
2018 | ||||
| 47. | Chloroquine reduces metastases of cholangiocarcinoma cells in lungs by tail vein assay of cancer metastasis | Kanokwan Nahok Diwakar Guragain Sopit Wongkham Wunchana Seubwai Ubon Cha'on |
2018 | ||||
| 48. | Potential prediction of patient survival and chemotherapeutic sensitivity in cholangiocarcinoma using FTIR microspectroscopy | Hahnvajanawong, C. Seubwai, W. Leelayuwat, C. Limpaiboon, T. Jearanaikoon, P. |
2018 | ||||
| 49. | Blocking of methionine aminopeptidase-2 by TNP-470 induces apoptosis and increases chemosensitivity of cholangiocarcinoma. | Sonexai Kidoikhammouan Wunchana Seubwai Atit Silsirivanit Sopit Wongkham Kanlayanee Sawanyawisuth Chaisiri Wongkham |
2019 | ||||
| 50. | Overexpression of HexCer and LacCer containing 2-hydroxylated fatty acids in cholangiocarcinoma and the association of the increase of LacCer (d18:1-h23:0) with shorter survival of the patients | Atit Silsirivanit Chatchai Phoomak Karuntarat Teeravirote Sasiprapa Wattanavises Wunchana Seubwai Charupong Saengboonmee Zhaoqi Zhan Jin-ichi Inokuchi Akemi Suzuki Sopit Wongkham |
2019 | ||||
| 51. | Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma | Sanmai, S Proungvitaya, T Limpaiboon, T Chua-On, D Seubwai, W Roytrakul, S Wongkham, S Wongkham, C Somintara, O Sangkhamanon, S Proungvitaya, S |
2019 | ||||
| 52. | Antitumor effect of Shikonin, a PKM2 inhibitor, in Cholangiocarcinoma cell lines | Thonsri, U Seubwai, W Waraasawapati, S Wongkham, S Boonmars, T Cha'on, U Wongkham, C |
2020 | ||||
| 53. | Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient. | Sripa, B. Seubwai, W. Vaeteewoottacharn, K. Sawanyawisuth, K. Silsirivanit, A. Kaewkong, W. Muisuk, K. Phoomak, C. Lert-Itthiporn, W. Pairojkul, C. Wongkham, S. Okada, S. Chamgramol, Y. |
2020 | ||||
| 54. | Multi-serum glycobiomarkers improves the diagnosis and prognostic prediction of cholangiocarcinoma | Silsirivanit, A Matsuda, A Kuno, A Tsuruno, C Uenoyama, Y Seubwai, W Angata, K Teeravirote, K Wongkham, C Araki, N Takahama, Y Wongkham, S Narimatsu, H |
2020 | ||||
| 55. | NF-κB and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells | Saengboonmee, C Phoomak, C Supabphol, S Covington, KR Hampton, O Wongkham, C Gibbs, RA Umezawa, K Seubwai, W Gingras, MC Wongkham, S |
2020 | ||||
| 56. | Aberrant GLUT1 expression is associated with carcinogenesis and progression of liver fluke-associated cholangiocarcinoma | Thamrongwaranggoon, U Sangkhamanon, S Seubwai, W Saranaruk, P Cha'on, U Wongkham, S |
2021 | ||||
| 57. | Association of Diabetes Mellitus and Cholangiocarcinoma: Update of Evidence and the Effects of Antidiabetic Medication. | Charupong Saengboonmee Wunchana Seubwai Worachart Lert-Itthiporn Thanachai Sanlung Sopit Wongkham |
2021 | ||||
| 58. | Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma | Prin Sungwan Worachart Lert-itthiporn Atit Silsirivanit Nathakan Klinhom-on Seiji Okada Sopit Wongkham Wunchana Seubwai |
2021 | ||||
| 59. | Cyclin A is upregulated by high glucose and a potential target for cholangiocarcinoma patients with diabetes mellitus | Charupong Saengboonmee Wunchana Seubwai Sakkarn Sangkhamanon Marutpong Detarya Kanlayanee Sawanyawisuth Atit Silsirivanit Sopit Wongkham |
2021 | ||||
| 60. | FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients. | Seubwai, W. Sawanyawisuth, K. Lert-Itthiporn, W. Waraasawapati, S. Wongkham, S. |
2021 | ||||
| 61. | FOXM1 inhibitor, Siomycin A, synergizes and restores 5-FU cytotoxicity in human cholangiocarcinoma cell lines via targeting thymidylate synthase. | Seubwai, W. Sawanyawisuth, K. Obchoei, S. Mahalapbutr, P. Wongkham, S. |
2021 | ||||
| 62. | High glucose: an emerging association between diabetes mellitus and cancer progression | Supabphol, S Seubwai, W Wongkham, S Saengboonmee, C |
2021 | ||||
| 63. | High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus | Saengboonmee, C. Sawanyawisuth, K. Seubwai, W. Wongkham, S. |
2021 | ||||
| 64. | High glucose-ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8 | Thonsri, U Wongkham, S Wongkham, C Hino, S Nakao, M Roytrakul, S Koga, T Seubwai, W |
2021 | ||||
| 65. | High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinoma | Seubwai, W. Phoomak, C. Saengboonmee, C. Wongkham, S. Wongkham, C. |
2021 | ||||
| 66. | Homophilic interaction of cd147 promotes il-6-mediated cholangiocarcinoma invasion via the nf-κb-dependent pathway | Paweena Dana Ryusho Kariya Worachart Lert-itthiporn Wunchana Seubwai Saowaluk Saisomboon Chaisiri Wongkham Seiji Okada Sopit Wongkham Kulthida Vaeteewoottacharn |
2021 | ||||
| 67. | Kallikrein-11, in association with coiled-coil domain containing 25, as a potential prognostic marker for cholangiocarcinoma with lymph node metastasis | Saeranee Siriphak Ravinnipa Chanakankun Tanakorn Proungvitaya Sittiruk Roytrakul Doungdean Tummanatsakun Wunchana Seubwai Molin Wongwattanakul Siriporn Proungvitaya |
2021 | ||||
| 68. | Lactic acidosis promotes aggressive features of cholangiocarcinoma cells via upregulating ALDH1A3 expression through EGFR axis. | Thamrongwaranggoon, U Detarya, M Seubwai, W Saengboomee, C Hino, S Koga, T Nakao, M Wongkham, S |
2022 | Count | 49 | 46 | 55 | 7 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | Total | ||||||
| 1. | Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: Implications for therapeutics | Seubwai, W. Wongkham, C. Puapairoj, A. Khuntikeo, N. Wongkham, S. |
2007 |
Cancer 12 (109), pp. 2497-2505 |
||||||||
| 2. | 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculutre of cholangiocarcinoma | Seubwai, W. Wongkham, C. Puapairoj, A. Okada, S. Wongkham, S. |
2010 |
Cancer 23 (116), pp. 5535-5543 |
||||||||
| 3. | Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-κB | Seubwai, W. Vaeteewoottacharn, K. Puapairoj, A. Okada, S. Wongkham, S. |
2010 |
Cancer Science 7 (101), pp. 1590-1595 |
||||||||
| 4. | Cepharanthine Suppresses Metastatic Potential of Human Cholangiocarcinoma Cell Lines | Uthaisar, K. Seubwai, W. Vaeteewoottacharn, K. Sawanyawisuth, K. Okada, S. Wongkham, S. |
2012 |
Asian Pacific Journal of Cancer Prevention SUPPL.1 (13), pp. 149-154 |
||||||||
| 5. | Hypoxia enhances aggressiveness of Cholangiocarcinoma cells | Seubwai, W. Kraiklang, R. Wongkham, C. Wongkham, S. |
2012 |
Asian Pacific Journal of Cancer Prevention SUPPL.1 (13), pp. 53-58 |
||||||||
| 6. | Involvement of p53 and nuclear factor-kappaB signaling pathway for the induction of G1-phase cell cycle arrest of cholangiocarcinoma cell lines by isomorellin | Hahnvajanawong, C. Ketnimit, S. Anantachoke, N. Sripa, B. Pinmai, K. Seubwai, W. Reutrakul, V. |
2012 |
Biological and Pharmaceutical Bulletin 11 (35), pp. 1914-1925 |
||||||||
| 7. | Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil | Hahnvajanawong, C. Chaiyagool, J. Seubwai, W. Bhudhisawasdi, V. Namwat, N. Khuntikeo, N. Sripa, B. Pugkhem, A. Tassaneeyakul, W. |
2012 |
World Journal of Gastroenterology 30 (18), pp. 3955-3961 |
||||||||
| 8. | TNP-470, A Methionine Aminopeptidase-2 Inhibitor, Inhibits Cell Proliferation, Migration and Invasion of Human Cholangiocarcinoma Cells In Vitro | Kidoikhammouan, S. Seubwai, W. Tantapotinan, N. Silsirivanit, A. Wongkham, S. Sawanyawisuth, K. Wongkham, C. |
2012 |
Asian Pacific Journal of Cancer Prevention SUPPL.1 (13), pp. 155-160 |
||||||||
| 9. | Establishment of an allo-transplantable hamster cholangiocarcinoma cell line and its application for in vivo screening of anti-cancer drugs | Puthdee, N. Vaeteewoottacharn, K. Seubwai, W. Wonkchalee, O. Kaewkong, W. Juasook, A. Pinlaor, S. Pairojkul, C. Wongkham, C. Okada, S. Boonmars, T. Wongkham, S. |
2013 |
Korean Journal of Parasitology 6 (51), pp. 711-717 |
||||||||
| 10. | Aberrant expression of NF-κB in liver fluke associated cholangiocarcinoma: Implications for targeted therapy | Seubwai, W. Wongkham, C. Puapairoj, A. Khuntikeo, N. Pugkhem, A. Hahnvajanawong, C. Chaiyagool, J. Umezawa, K. Okada, S. Wongkham, S. |
2014 |
PLoS ONE 8 (9), pp. |
||||||||
| 11. | Association between cellular radiosensitivity and G1/G2 checkpoint proficiencies in human cholangiocarcinoma cell lines | Hematulin, A. Sagan, D.L. Sawanyawisuth, K. Seubwai, W. Wongkham, S. |
2014 |
International Journal of Oncology 3 (45), pp. 1159-1166 |
||||||||
| 12. | High expression of HIF-1α, BNIP3 and PI3KC3: Hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis | Thongchot, S. Yongvanit, P. Loilome, W. Seubwai, W. Phunicom, K. Tassaneeyakul, W. Pairojkul, C. Promkotra, W. Techasen, A. Namwat, N. |
2014 |
Asian Pacific Journal of Cancer Prevention 14 (15), pp. 5873-5878 |
||||||||
| 13. | In vitro and in vivo antitumor activity of tiliacorinine in human cholangiocarcinoma | Janeklang, S. Nakaew, A. Vaeteewoottacharn, K. Seubwai, W. Boonsiri, P. Kismali, G. Suksamrarn, A. Okada, S. Wongkham, S. |
2014 |
Asian Pacific Journal of Cancer Prevention 17 (15), pp. 7473-7478 |
||||||||
| 14. | Potential targeted therapy for liver fluke associated cholangiocarcinoma | Vaeteewoottacharn, K. Seubwai, W. Bhudhisawasdi, V. Okada, S. Wongkham, S. |
2014 |
Journal of Hepato-Biliary-Pancreatic Sciences 6 (21), pp. 362-370 |
||||||||
| 15. | Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma. Association of diabetes mellitus and cholangiocarcinoma | Saengboonmee, C. Seubwai, W. Wongkham, C. Wongkham, S. |
2015 |
Cancer Epidemiology 3 (39), pp. 274-278 |
||||||||
| 16. | Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness | Wattanawongdon, W. Hahnvajanawong, C. Namwat, N. Kanchanawat, S. Boonmars, T. Jearanaikoon, P. Leelayuwat, C. Techasen, A. Seubwai, W. |
2015 |
International Journal of Oncology 1 (47), pp. 398-410 |
||||||||
| 17. | Improve discrimination power of serum markers for diagnosis of cholangiocarcinoma using data mining-based approach | Pattanapairoj, S. Silsirivanit, A. Muisuk, K. Seubwai, W. Cha'on, U. Vaeteewoottacharn, K. Sawanyawisuth, K. Chetchotsak, D. Wongkham, S. |
2015 |
Clinical Biochemistry 10-11 (48), pp. 668-673 |
||||||||
| 18. | Establishment and characterization of a novel human cholangiocarcinoma cell line with high metastatic activity | Uthaisar, K. Vaeteewoottacharn, K. Seubwai, W. Talabnin, C. Sawanyawisuth, K. Obchoei, S. Kraiklang, R. Okada, S. Wongkham, S. |
2016 |
Oncology Reports 3 (36), pp. 1435-1446 |
||||||||
| 19. | High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation | Saengboonmee, C. Seubwai, W. Pairojkul, C. Wongkham, S. |
2016 |
Scientific Reports (6), pp. |
||||||||
| 20. | Inhibition of NF-κB activity enhances sensitivity to anticancer drugs in cholangiocarcinoma cells | Seubwai, W. Vaeteewoottacharn, K. Kraiklang, R. Okada, S. Wongkham, S. |
2016 |
Oncology Research 1-2 (23), pp. 21-28 |
||||||||
| 21. | Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB | Phoomak, C. Vaeteewoottacharn, K. Sawanyawisuth, K. Seubwai, W. Wongkham, C. Silsirivanit, A. Wongkham, S. |
2016 |
Scientific Reports (6), pp. |
||||||||
| 22. | Targeted delivery of 5-fluorouracil to cholangiocarcinoma cells using folic acid as a targeting agent | Ngernyuang, N. Seubwai, W. Daduang, S. Boonsiri, P. Limpaiboon, T. Daduang, J. |
2016 |
Materials Science and Engineering C (60), pp. 411-415 |
||||||||
| 23. | Berberine induces cell cycle arrest in cholangiocarcinoma cell lines via inhibition of NF-κB and STAT3 pathways | Puthdee, N. Seubwai, W. Vaeteewoottacharn, K. Boonmars, T. Cha'on, U. Phoomak, C. |
2017 |
Biological and Pharmaceutical Bulletin 6 (40), pp. 751-757 |
||||||||
| 24. | High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation | Phoomak, C. Vaeteewoottacharn, K. Silsirivanit, A. Saengboonmee, C. Seubwai, W. Sawanyawisuth, K. Wongkham, C. |
2017 |
Scientific Reports (7), pp. |
||||||||
| 25. | Metformin exerts antiproliferative and anti-metastatic effects against cholangiocarcinoma cells by targeting STAT3 and NF-κB | Saengboonmee, C. Seubwai, W. Cha'on, U. Sawanyawisuth, K. Wongkham, C. |
2017 |
Anticancer Research 1 (37), pp. 115-123 |
||||||||
| 26. | Overexpression of lactate dehydrogenase A in cholangiocarcinoma is correlated with poor prognosis | Seubwai, W. Waraasawapati, S. Sawanyawisuth, K. Vaeteewoottacharn, K. Chaon, U. |
2017 |
Histology and Histopathology 5 (32), pp. 503-510 |
||||||||
| 27. | Targeting hexokinase II as a possible therapy for cholangiocarcinoma | Seubwai, W. Phoomak, C. Cha'on, U. Boonmars, T. |
2017 |
Biochemical and Biophysical Research Communications 2 (484), pp. 409-415 |
||||||||
| 28. | Upregulation of CD147 promotes metastasis of cholangiocarcinoma by modulating the epithelial-to-mesenchymal transitional process | Vaeteewoottacharn, K. Sawanyawisuth, K. Seubwai, W. |
2017 |
Oncology Research 7 (25), pp. 1047-1059 |
||||||||
| 29. | Activation of vimentin is critical to promote a metastatic potential of cholangiocarcinoma cells | Vaeteewoottacharn, K. Silsirivanit, A. Seubwai, W. Talabnin, C. Muisuk, K. Sripa, B. Wongkham, S. Okada, S. Wongkham, C. |
2018 |
Oncology Research 4 (26), pp. 605-616 |
||||||||
| 30. | Artesunate and chloroquine induce cytotoxic activity on cholangiocarcinoma cells via different cell death mechanisms | Seubwai, W. Kobayashi, D. Vaeteewoottacharn, K. Sawanyawisuth, K. Wongkham, C. Wongkham, S. |
2018 |
Cellular and Molecular Biology 10 (64), pp. 113-118 |
||||||||
| 31. | Potential prediction of patient survival and chemotherapeutic sensitivity in cholangiocarcinoma using FTIR microspectroscopy | Hahnvajanawong, C. Seubwai, W. Leelayuwat, C. Limpaiboon, T. Jearanaikoon, P. |
2018 |
Journal of Molecular Structure (1166), pp. 416-421 |
||||||||
| 32. | Blocking of methionine aminopeptidase-2 by TNP-470 induces apoptosis and increases chemosensitivity of cholangiocarcinoma | Kidoikhammouan, S. Seubwai, W. Silsirivanit, A. Wongkham, S. Sawanyawisuth, K. Wongkham, C. |
2019 |
Journal of Cancer Research and Therapeutics 1 (15), pp. 148-152 |
||||||||
| 33. | Overexpression of HexCer and LacCer containing 2-hydroxylated fatty acids in cholangiocarcinoma and the association of the increase of LacCer (d18:1-h23:0) with shorter survival of the patients | Silsirivanit, A. Phoomak, C. Seubwai, W. Saengboonmee, C. Wongkham, S. |
2019 |
Glycoconjugate Journal (), pp. |
||||||||
| 34. | Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma | Proungvitaya, T. Limpaiboon, T. Seubwai, W. Wongkham, S. Wongkham, C. Somintara, O. Patrakitkomjorn, S. |
2019 |
Oncology Letters 6 (17), pp. 5275-5282 |
||||||||
| 35. | Antitumor effect of Shikonin, a PKM2 inhibitor, in Cholangiocarcinoma cell lines | Seubwai, W. Waraasawapati, S. Wongkham, S. Cha'on, U. Wongkham, C. |
2020 |
Anticancer Research 9 (40), pp. 5115-5124 |
||||||||
| 36. | Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient | Sripa, B. Seubwai, W. Vaeteewoottacharn, K. Sawanyawisuth, K. Silsirivanit, A. Kaewkong, W. Muisuk, K. Phoomak, C. Lert-Itthiporn, W. Pairojkul, C. Wongkham, S. Okada, S. Chamgramol, Y. |
2020 |
Human Cell 3 (33), pp. 695-708 |
||||||||
| 37. | Multi-serum glycobiomarkers improves the diagnosis and prognostic prediction of cholangiocarcinoma | Silsirivanit, A. Seubwai, W. Wongkham, C. Wongkham, S. |
2020 |
Clinica Chimica Acta (510), pp. 142-149 |
||||||||
| 38. | NF-κB and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells | Saengboonmee, C. Phoomak, C. Wongkham, C. Seubwai, W. Wongkham, S. |
2020 |
Life Sciences (262), pp. |
||||||||
| 39. | Aberrant GLUT1 expression is associated with carcinogenesis and progression of liver fluke-associated cholangiocarcinoma | Seubwai, W. Cha'on, U. Wongkham, S. |
2021 |
In Vivo 1 (35), pp. 267-274 |
||||||||
| 40. | Association of Diabetes Mellitus and Cholangiocarcinoma: Update of Evidence and the Effects of Antidiabetic Medication | Saengboonmee, C. Seubwai, W. Lert-Itthiporn, W. Wongkham, S. |
2021 |
Canadian Journal of Diabetes 3 (45), pp. 282-290 |
||||||||
| 41. | Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma | Lert-Itthiporn, W. Silsirivanit, A. Okada, S. Wongkham, S. Seubwai, W. |
2021 |
PeerJ (9), pp. |
||||||||
| 42. | FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients | Seubwai, W. Sawanyawisuth, K. Lert-Itthiporn, W. Waraasawapati, S. Wongkham, S. |
2021 |
Heliyon 4 (7), pp. |
||||||||
| 43. | FOXM1 inhibitor, Siomycin A, synergizes and restores 5-FU cytotoxicity in human cholangiocarcinoma cell lines via targeting thymidylate synthase | Seubwai, W. Sawanyawisuth, K. Obchoei, S. Mahalapbutr, P. Wongkham, S. |
2021 |
Life Sciences (286), pp. |
||||||||
| 44. | High glucose: an emerging association between diabetes mellitus and cancer progression | Seubwai, W. Wongkham, S. Saengboonmee, C. |
2021 |
Journal of Molecular Medicine 9 (99), pp. 1175-1193 |
||||||||
| 45. | High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus | Saengboonmee, C. Sawanyawisuth, K. Seubwai, W. Wongkham, S. |
2021 |
Nutrition and Cancer (), pp. |
||||||||
| 46. | High glucose-ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8 | Wongkham, S. Wongkham, C. Seubwai, W. |
2021 |
Cancer Science 1 (112), pp. 254-264 |
||||||||
| 47. | High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinoma | Seubwai, W. Phoomak, C. Saengboonmee, C. Wongkham, S. Wongkham, C. |
2021 |
Life Sciences (271), pp. |
||||||||
| 48. | Homophilic interaction of cd147 promotes il-6-mediated cholangiocarcinoma invasion via the nf-κb-dependent pathway | Lert-Itthiporn, W. Seubwai, W. Saisomboon, S. Wongkham, C. Okada, S. Wongkham, S. Vaeteewoottacharn, K. |
2021 |
International Journal of Molecular Sciences 24 (22), pp. |
||||||||
| 49. | Kallikrein-11, in association with coiled-coil domain containing 25, as a potential prognostic marker for cholangiocarcinoma with lymph node metastasis | Chanakankun, R. Proungvitaya, T. Seubwai, W. Wongwattanakul, M. Patrakitkomjorn, S. |
2021 |
Molecules 11 (26), pp. |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: implications for therapeutics. | Seubwai, W Wongkham, C Puapairoj, A Khuntikeo, N Wongkham, S |
2007 |
Cancer 12 (109), pp. 2497-505 |
|
| 2. | 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma. | Seubwai, W Wongkham, C Puapairoj, A Okada, S Wongkham, S |
2010 |
Cancer 23 (116), pp. 5535-43 |
|
| 3. | Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-kappaB. | Seubwai, W Vaeteewoottacharn, K Hiyoshi, M Suzu, S Puapairoj, A Wongkham, C Okada, S Wongkham, S |
2010 |
Cancer science 7 (101), pp. 1590-5 |
|
| 4. | Hypoxia enhances aggressiveness of cholangiocarcinoma cells. | Seubwai, W Kraiklang, R Wongkham, C Wongkham, S |
2012 |
Asian Pacific journal of cancer prevention : APJCP (13), pp. 53-8 |
|
| 5. | TNP-470, a methionine aminopeptidase-2 inhibitor, inhibits cell proliferation, migration and invasion of human cholangiocarcinoma cells in vitro. | Kidoikhammouan, S Seubwai, W Tantapotinan, N Silsirivanit, A Wongkham, S Sawanyawisuth, K Wongkham, C |
2012 |
Asian Pacific journal of cancer prevention : APJCP (13), pp. 155-60 |
|
| 6. | Cepharanthine suppresses metastatic potential of human cholangiocarcinoma cell lines. | Uthaisar, K Seubwai, W Srikoon, P Vaeteewoottacharn, K Sawanyawisuth, K Okada, S Wongkham, S |
2012 |
Asian Pacific journal of cancer prevention : APJCP (13), pp. 149-54 |
|
| 7. | Involvement of p53 and nuclear factor-kappaB signaling pathway for the induction of G1-phase cell cycle arrest of cholangiocarcinoma cell lines by isomorellin. | Hahnvajanawong, C Ketnimit, S Pattanapanyasat, K Anantachoke, N Sripa, B Pinmai, K Seubwai, W Reutrakul, V |
2012 |
Biological & pharmaceutical bulletin 11 (35), pp. 1914-25 |
|
| 8. | Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil. | Hahnvajanawong, C Chaiyagool, J Seubwai, W Bhudhisawasdi, V Namwat, N Khuntikeo, N Sripa, B Pugkhem, A Tassaneeyakul, W |
2012 |
World journal of gastroenterology : WJG 30 (18), pp. 3955-61 |
|
| 9. | Establishment of an allo-transplantable hamster cholangiocarcinoma cell line and its application for in vivo screening of anti-cancer drugs. | Puthdee, N Vaeteewoottacharn, K Seubwai, W Wonkchalee, O Kaewkong, W Juasook, A Pinlaor, S Pairojkul, C Wongkham, C Okada, S Boonmars, T Wongkham, S |
2013 |
The Korean journal of parasitology 6 (51), pp. 711-7 |
|
| 10. | Association between cellular radiosensitivity and G1/G2 checkpoint proficiencies in human cholangiocarcinoma cell lines. | Hematulin, A Sagan, D Sawanyawisuth, K Seubwai, W Wongkham, S |
2014 |
International journal of oncology 3 (45), pp. 1159-66 |
|
| 11. | Potential targeted therapy for liver fluke associated cholangiocarcinoma. | Vaeteewoottacharn, K Seubwai, W Bhudhisawasdi, V Okada, S Wongkham, S |
2014 |
Journal of hepato-biliary-pancreatic sciences 6 (21), pp. 362-70 |
|
| 12. | In vitro and in vivo antitumor activity of tiliacorinine in human cholangiocarcinoma. | Janeklang, S Nakaew, A Vaeteewoottacharn, K Seubwai, W Boonsiri, P Kismali, G Suksamrarn, A Okada, S Wongkham, S |
2014 |
Asian Pacific journal of cancer prevention : APJCP 17 (15), pp. 7473-8 |
|
| 13. | High expression of HIF-1α, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis. | Thongchot, S Yongvanit, P Loilome, W Seubwai, W Phunicom, K Tassaneeyakul, W Pairojkul, C Promkotra, W Techasen, A Namwat, N |
2014 |
Asian Pacific journal of cancer prevention : APJCP 14 (15), pp. 5873-8 |
|
| 14. | Aberrant expression of NF-κB in liver fluke associated cholangiocarcinoma: implications for targeted therapy. | Seubwai, W Wongkham, C Puapairoj, A Khuntikeo, N Pugkhem, A Hahnvajanawong, C Chaiyagool, J Umezawa, K Okada, S Wongkham, S |
2014 |
PloS one 8 (9), pp. e106056 |
|
| 15. | Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness. | Wattanawongdon, W Hahnvajanawong, C Namwat, N Kanchanawat, S Boonmars, T Jearanaikoon, P Leelayuwat, C Techasen, A Seubwai, W |
2015 |
International journal of oncology 1 (47), pp. 398-410 |
|
| 16. | Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma: Association of diabetes mellitus and cholangiocarcinoma. | Saengboonmee, C Seubwai, W Wongkham, C Wongkham, S |
2015 |
Cancer epidemiology 3 (39), pp. 274-8 |
|
| 17. | Improve discrimination power of serum markers for diagnosis of cholangiocarcinoma using data mining-based approach. | Pattanapairoj, S Silsirivanit, A Muisuk, K Seubwai, W Cha'on, U Vaeteewoottacharn, K Sawanyawisuth, K Chetchotsak, D Wongkham, S |
2015 |
Clinical biochemistry 10 (48), pp. 668-73 |
|
| 18. | High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation. | Saengboonmee, C Seubwai, W Pairojkul, C Wongkham, S |
2016 |
Scientific reports (6), pp. 18995 |
|
| 19. | Inhibition of NF-κB Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells. | Seubwai, W Vaeteewoottacharn, K Kraiklang, R Umezawa, K Okada, S Wongkham, S |
2016 |
Oncology research 1 (23), pp. 21-8 |
|
| 20. | Establishment and characterization of a novel human cholangiocarcinoma cell line with high metastatic activity. | Uthaisar, K Vaeteewoottacharn, K Seubwai, W Talabnin, C Sawanyawisuth, K Obchoei, S Kraiklang, R Okada, S Wongkham, S |
2016 |
Oncology reports 3 (36), pp. 1435-46 |
|
| 21. | Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB. | Phoomak, C Vaeteewoottacharn, K Sawanyawisuth, K Seubwai, W Wongkham, C Silsirivanit, A Wongkham, S |
2016 |
Scientific reports (6), pp. 27853 |
|
| 22. | Overexpression of lactate dehydrogenase A in cholangiocarcinoma is correlated with poor prognosis. | Thonsri, U Seubwai, W Waraasawapati, S Sawanyawisuth, K Vaeteewoottacharn, K Boonmars, T Cha'on, U |
2016 |
Histology and histopathology (), pp. 11819 |
|
| 23. | Targeted delivery of 5-fluorouracil to cholangiocarcinoma cells using folic acid as a targeting agent. | Ngernyuang, N Seubwai, W Daduang, S Boonsiri, P Limpaiboon, T Daduang, J |
2016 |
Materials science & engineering. C, Materials for biological applications (60), pp. 411-5 |
|
| 24. | Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-ĸB. | Saengboonmee, C Seubwai, W Cha'on, U Sawanyawisuth, K Wongkham, S Wongkham, C |
2017 |
Anticancer research 1 (37), pp. 115-123 |
|
| 25. | Targeting hexokinase II as a possible therapy for cholangiocarcinoma. | Thamrongwaranggoon, U Seubwai, W Phoomak, C Sangkhamanon, S Cha'on, U Boonmars, T Wongkham, S |
2017 |
Biochemical and biophysical research communications 2 (484), pp. 409-415 |
|
| 26. | High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation. | Phoomak, C Vaeteewoottacharn, K Silsirivanit, A Saengboonmee, C Seubwai, W Sawanyawisuth, K Wongkham, C Wongkham, S |
2017 |
Scientific reports (7), pp. 43842 |
|
| 27. | Berberine Induces Cell Cycle Arrest in Cholangiocarcinoma Cell Lines via Inhibition of NF-κB and STAT3 Pathways. | Puthdee, N Seubwai, W Vaeteewoottacharn, K Boonmars, T Cha'on, U Phoomak, C Wongkham, S |
2017 |
Biological & pharmaceutical bulletin 6 (40), pp. 751-757 |
|
| 28. | Upregulation of CD147 Promotes Metastasis of Cholangiocarcinoma by Modulating the Epithelial-to-Mesenchymal Transitional Process. | Dana, P Kariya, R Vaeteewoottacharn, K Sawanyawisuth, K Seubwai, W Matsuda, K Okada, S Wongkham, S |
2017 |
Oncology research 7 (25), pp. 1047-1059 |
|
| 29. | Activation of Vimentin Is Critical to Promote a Metastatic Potential of Cholangiocarcinoma Cells. | Saentaweesuk, W Araki, N Vaeteewoottacharn, K Silsirivanit, A Seubwai, W Talabnin, C Muisuk, K Sripa, B Wongkham, S Okada, S Wongkham, C |
2018 |
Oncology research 4 (26), pp. 605-616 |
|
| 30. | Artesunate and chloroquine induce cytotoxic activity on cholangiocarcinoma cells via different cell death mechanisms. | Guragain, D Seubwai, W Kobayashi, D Silsinivanit, A Vaeteewoottacharn, K Sawanyawisuth, K Wongkham, C Wongkham, S Araki, N Cha'on, U |
2018 |
Cellular and molecular biology (Noisy-le-Grand, France) 10 (64), pp. 113-118 |
|
| 31. | Blocking of methionine aminopeptidase-2 by TNP-470 induces apoptosis and increases chemosensitivity of cholangiocarcinoma. | Kidoikhammouan, S Seubwai, W Silsirivanit, A Wongkham, S Sawanyawisuth, K Wongkham, C |
2019 |
Journal of cancer research and therapeutics 1 (15), pp. 148-152 |
|
| 32. | Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma. | Sanmai, S Proungvitaya, T Limpaiboon, T Chua-On, D Seubwai, W Roytrakul, S Wongkham, S Wongkham, C Somintara, O Sangkhamanon, S Proungvitaya, S |
2019 |
Oncology letters 6 (17), pp. 5275-5282 |
|
| 33. | Overexpression of HexCer and LacCer containing 2-hydroxylated fatty acids in cholangiocarcinoma and the association of the increase of LacCer (d18:1-h23:0) with shorter survival of the patients. | Silsirivanit, A Phoomak, C Teeravirote, K Wattanavises, S Seubwai, W Saengboonmee, C Zhan, Z Inokuchi, JI Suzuki, A Wongkham, S |
2019 |
Glycoconjugate journal 2 (36), pp. 103-111 |
|
| 34. | NF-κB and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells. | Saengboonmee, C Phoomak, C Supabphol, S Covington, KR Hampton, O Wongkham, C Gibbs, RA Umezawa, K Seubwai, W Gingras, MC Wongkham, S |
2020 |
Life sciences (262), pp. 118548 |
|
| 35. | Antitumor Effect of Shikonin, a PKM2 Inhibitor, in Cholangiocarcinoma Cell Lines. | Thonsri, U Seubwai, W Waraasawapati, S Wongkham, S Boonmars, T Cha'on, U Wongkham, C |
2020 |
Anticancer research 9 (40), pp. 5115-5124 |
|
| 36. | Multi-serum glycobiomarkers improves the diagnosis and prognostic prediction of cholangiocarcinoma. | Silsirivanit, A Matsuda, A Kuno, A Tsuruno, C Uenoyama, Y Seubwai, W Angata, K Teeravirote, K Wongkham, C Araki, N Takahama, Y Wongkham, S Narimatsu, H |
2020 |
Clinica chimica acta; international journal of clinical chemistry (510), pp. 142-149 |
|
| 37. | Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient. | Sripa, B Seubwai, W Vaeteewoottacharn, K Sawanyawisuth, K Silsirivanit, A Kaewkong, W Muisuk, K Dana, P Phoomak, C Lert-Itthiporn, W Luvira, V Pairojkul, C Teh, BT Wongkham, S Okada, S Chamgramol, Y |
2020 |
Human cell 3 (33), pp. 695-708 |
|
| 38. | High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus. | Saengboonmee, C Detarya, M Sangkhamanon, S Sawanyawisuth, K Seubwai, W Wongkham, S |
2021 |
Nutrition and cancer (), pp. 1-11 |
|
| 39. | Association of Diabetes Mellitus and Cholangiocarcinoma: Update of Evidence and the Effects of Antidiabetic Medication. | Saengboonmee, C Seubwai, W Lert-Itthiporn, W Sanlung, T Wongkham, S |
2021 |
Canadian journal of diabetes 3 (45), pp. 282-290 |
|
| 40. | Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma. | Sungwan, P Lert-Itthiporn, W Silsirivanit, A Klinhom-On, N Okada, S Wongkham, S Seubwai, W |
2021 |
PeerJ (9), pp. e11067 |
|
| 41. | High glucose-ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8. | Thonsri, U Wongkham, S Wongkham, C Hino, S Nakao, M Roytrakul, S Koga, T Seubwai, W |
2021 |
Cancer science 1 (112), pp. 254-264 |
|
| 42. | Aberrant GLUT1 Expression Is Associated With Carcinogenesis and Progression of Liver Fluke-associated Cholangiocarcinoma. | Thamrongwaranggoon, U Sangkhamanon, S Seubwai, W Saranaruk, P Cha'on, U Wongkham, S |
2021 |
In vivo (Athens, Greece) 1 (35), pp. 267-274 |
|
| 43. | FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients. | Klinhom-On, N Seubwai, W Sawanyawisuth, K Lert-Itthiporn, W Waraasawapati, S Detarya, M Wongkham, S |
2021 |
Heliyon 4 (7), pp. e06846 |
|
| 44. | FOXM1 inhibitor, Siomycin A, synergizes and restores 5-FU cytotoxicity in human cholangiocarcinoma cell lines via targeting thymidylate synthase. | Klinhom-On, N Seubwai, W Sawanyawisuth, K Obchoei, S Mahalapbutr, P Wongkham, S |
2021 |
Life sciences (), pp. 120072 |
|
| 45. | High glucose: an emerging association between diabetes mellitus and cancer progression. | Supabphol, S Seubwai, W Wongkham, S Saengboonmee, C |
2021 |
Journal of molecular medicine (Berlin, Germany) 9 (99), pp. 1175-1193 |
|
| 46. | Lactic acidosis promotes aggressive features of cholangiocarcinoma cells via upregulating ALDH1A3 expression through EGFR axis. | Thamrongwaranggoon, U Detarya, M Seubwai, W Saengboomee, C Hino, S Koga, T Nakao, M Wongkham, S |
2022 |
Life sciences (), pp. 120648 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | Total | ||||||
| 1. | Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma - Implications for therapeutics | Wunchana Seubwai Chaisiri Wongkham Anucha Puapairoj Narong Khuntikeo Sopit Wongkham |
2007 |
CANCER 12.0 (109.0), pp. 2497.0-2505.0 |
52 | 0 | 0 | 0 | 0 | 0 | 52 | |
| 2. | Vitamin D suppresses tumour growth and enhances cyto-toxicity of chemotherapeutic agents in cholangiocarcinoma | S. Woncikham W. Seubwail C. Wongkham A. Puapairoj S. Okada |
2008 |
EJC SUPPLEMENTS 9.0 (6.0), pp. 154.0-154.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 3. | 22-Oxa-1,25-Dihydroxyvitamin D-3 Efficiently Inhibits Tumor Growth in Inoculated Mice and Primary Histoculutre of Cholangiocarcinoma | Wunchana Seubwai Chaisiri Wongkham Anucha Puapairoj Seiji Okada Sopit Wongkham |
2010 |
CANCER 23.0 (116.0), pp. 5535.0-5543.0 |
23 | 0 | 0 | 0 | 0 | 0 | 23 | |
| 4. | Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-kappa B | Wunchana Seubwai Kulthida Vaeteewoottacharn Masateru Hiyoshi Shinya Suzu Anucha Puapairoj Chairisi Wongkham Seiji Okada Sopit Wongkham |
2010 |
CANCER SCIENCE 7.0 (101.0), pp. 1590.0-1595.0 |
59 | 0 | 0 | 0 | 0 | 0 | 59 | |
| 5. | CEPHARANTHINE EXERTS ANTITUMOR ACTIVITY ON CHOLANGIOCARCINOMA BY INHIBITION OF NF-KB ACTION | W. Seubwai K. Vaeteewoottacharn A. Puapairoj C. Wongkham S. Okada S. Wongkham |
2011 |
JOURNAL OF HEPATOLOGY (54.0), pp. S59-S59 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 6. | Cepharanthine Suppresses Metastatic Potential of Human Cholangiocarcinoma Cell Lines | Kwuntida Uthaisar Wunchana Seubwai Pattravedee Srikoon Kulthida Vaeteewoottacharn Kanlayanee Sawanyawisuth Seiji Okada Sopit Wongkham |
2012 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (13.0), pp. 149.0-154.0 |
17 | 0 | 0 | 0 | 0 | 0 | 17 | |
| 7. | Hypoxia Enhances Aggressiveness of Cholangiocarcinoma Cells | Wunchana Seubwai Ratthaphol Kraiklang Chaisiri Wongkham Sopit Wongkham |
2012 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (13.0), pp. 53.0-58.0 |
15 | 0 | 0 | 0 | 0 | 0 | 15 | |
| 8. | Involvement of p53 and Nuclear Factor-kappaB Signaling Pathway for the Induction of G1-Phase Cell Cycle Arrest of Cholangiocarcinoma Cell Lines by Isomorellin | Chariya Hahnvajanawong Supaluk Ketnimit Kovit Pattanapanyasat Natthinee Anantachoke Banchob Sripa Khosit Pinmai Wunchana Seubwai Vichai Reutrakul |
2012 |
BIOLOGICAL & PHARMACEUTICAL BULLETIN 11.0 (35.0), pp. 1914.0-1925.0 |
23 | 0 | 0 | 0 | 0 | 0 | 23 | |
| 9. | Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil | Chariya Hahnvajanawong Jariya Chaiyagool Wunchana Seubwai Vajarabhongsa Bhudhisawasdi Nisana Namwat Narong Khuntikeo Banchob Sripa Ake Pugkhem Wichittra Tassaneeyakul |
2012 |
WORLD JOURNAL OF GASTROENTEROLOGY 30.0 (18.0), pp. 3955.0-3961.0 |
20 | 0 | 0 | 0 | 0 | 0 | 20 | |
| 10. | TNP-470, A Methionine Aminopeptidase-2 Inhibitor, Inhibits Cell Proliferation, Migration and Invasion of Human Cholangiocarcinoma Cells In Vitro | Sonexai Kidoikhammouan Wunchana Seubwai Nattawat Tantapotinan Atit Silsirivanit Sopit Wongkham Kanlayanee Sawanyawisuth Chaisiri Wongkham |
2012 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (13.0), pp. 155.0-160.0 |
9 | 0 | 0 | 0 | 0 | 0 | 9 | |
| 11. | Establishment of an Allo-Transplantable Hamster Cholangiocarcinoma Cell Line and Its Application for In Vivo Screening of Anti-Cancer Drugs | Nattapong Puthdee Kulthida Vaeteewoottacharn Wunchana Seubwai Orasa Wonkchalee Worasak Kaewkong Amornrat Juasook Somchai Pinlaor Chawalit Pairojkul Chaisiri Wongkham Seiji Okada Thidarut Boonmars Sopit Wongkham |
2013 |
KOREAN JOURNAL OF PARASITOLOGY 6.0 (51.0), pp. 711.0-717.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 12. | Aberrant Expression of NF-kappa B in Liver Fluke Associated Cholangiocarcinoma: Implications for Targeted Therapy | Wunchana Seubwai Chaisiri Wongkham Anucha Puapairoj Narong Khuntikeo Ake Pugkhem Chariya Hahnvajanawong Jariya Chaiyagool Kazuo Umezawa Seiji Okada Sopit Wongkham |
2014 |
PLOS ONE 8.0 (9.0), pp. |
35 | 0 | 0 | 0 | 0 | 0 | 35 | |
| 13. | A NOVEL ANTICANCER ALKALOID TILIACORININE INDUCES SUSTAINED ACTIVATION OF THE EXTRACELLULAR SIGNAL-REGULATED KINASE AND SYNERGIZES WITH CISPLATIN IN CHOLANGIOCARCINOMA CELLS | S. Janeklang W. Seubwai K. Vaeteewoottacharn P. Boonsiri G. Kismali A. Nakaew A. Suksamrarn S. Okada S. Wongkham |
2014 |
ANTICANCER RESEARCH 10.0 (34.0), pp. 5970.0-5970.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 14. | Association between cellular radiosensitivity and G1/G2 checkpoint proficiencies in human cholangiocarcinoma cell lines | Arunee Hematulin Daniel Sagan Kanlayanee Sawanyawisuth Wunchana Seubwai Sopit Wongkham |
2014 |
INTERNATIONAL JOURNAL OF ONCOLOGY 3.0 (45.0), pp. 1159.0-1166.0 |
16 | 0 | 0 | 0 | 0 | 0 | 16 | |
| 15. | High Expression of HIF-1 alpha, BNIP3 and PI3KC3: Hypoxia-Induced Autophagy Predicts Cholangiocarcinoma Survival and Metastasis | Suyanee Thongchot Puangrat Yongvanit Watcharin Loilome Wanchana Seubwai Kutcharin Phunicom Wichittra Tassaneeyakul Chawalit Pairojkul Wisuttiphong Promkotra Anchalee Techasen Nisana Namwat |
2014 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION 14.0 (15.0), pp. 5873.0-5878.0 |
37 | 0 | 0 | 0 | 0 | 0 | 37 | |
| 16. | In vitro and In vivo Antitumor Activity of Tiliacorinine in Human Cholangiocarcinoma | Somkid Janeklang Archawin Nakaew Kulthida Vaeteewoottacharn Wunchana Seubwai Patcharee Boonsiri Gorkem Kismali Apichart Suksamrarn Seiji Okada Sopit Wongkham |
2014 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION 17.0 (15.0), pp. 7473.0-7478.0 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 17. | Potential targeted therapy for liver fluke associated cholangiocarcinoma | Kulthida Vaeteewoottacharn Wunchana Seubwai Vajarabhongsa Bhudhisawasdi Seiji Okada Sopit Wongkham |
2014 |
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES 6.0 (21.0), pp. 362.0-370.0 |
11 | 0 | 0 | 0 | 0 | 0 | 11 | |
| 18. | Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma Association of diabetes mellitus and cholangiocarcinoma | Charupong Saengboonmee Wunchana Seubwai Chaisiri Wongkham Sopit Wongkham |
2015 |
CANCER EPIDEMIOLOGY 3.0 (39.0), pp. 274.0-278.0 |
16 | 0 | 0 | 0 | 0 | 0 | 16 | |
| 19. | Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness | Wareeporn Wattanawongdon Chariya Hahnvajanawong Nisana Namwat Sirimas Kanchanawat Thidarut Boonmars Patcharee Jearanaikoon Chanwit Leelayuwat Anchalee Techasen Wunchana Seubwai |
2015 |
INTERNATIONAL JOURNAL OF ONCOLOGY 1.0 (47.0), pp. 398.0-410.0 |
34 | 0 | 0 | 0 | 0 | 0 | 34 | |
| 20. | Improve discrimination power of serum markers for diagnosis of cholangiocarcinoma using data mining-based approach | Sirorat Pattanapairoj Atit Silsirivanit Kanha Muisuk Wunchana Seubwai Ubon Cha'on Kulthida Vaeteewoottacharn Kanlayanee Sawanyawisuth Danaipong Chetchotsak Sopit Wongkham |
2015 |
CLINICAL BIOCHEMISTRY 10-11 (48.0), pp. 668.0-673.0 |
19 | 0 | 0 | 0 | 0 | 0 | 19 | |
| 21. | Inhibition of NF-kappa B Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells | Wunchana Seubwai Kulthida Vaeteewoottacharn Ratthaphol Kraiklang Kazuo Umezawa Seiji Okada Sopit Wongkham |
2015 |
ONCOLOGY RESEARCH 1-2 (23.0), pp. 21.0-28.0 |
24 | 0 | 0 | 0 | 0 | 0 | 24 | |
| 22. | Synthesis of 5-fluorouracil nanoparticles and its inhibition of Cholangiocarcinoma in vitro | N. Ngernyuang W. Seubwai S. Daduang P. Boonsiri T. Limpaiboon J. Daduang |
2015 |
EUROPEAN JOURNAL OF CANCER (51.0), pp. S135-S135 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 23. | Establishment and characterization of a novel human cholangiocarcinoma cell line with high metastatic activity | Kwuntida Uthaisar Kulthida Vaeteewoottacharn Wunchana Seubwai Chutima Talabnin Kanlayanee Sawanyawisuth Sumalee Obchoei Ratthaphol Kraiklang Seiji Okada Sopit Wongkham |
2016 |
ONCOLOGY REPORTS 3.0 (36.0), pp. 1435.0-1446.0 |
20 | 0 | 0 | 0 | 0 | 0 | 20 | |
| 24. | High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation | Charupong Saengboonmee Wunchana Seubwai Chawalit Pairojkul Sopit Wongkham |
2016 |
SCIENTIFIC REPORTS (6.0), pp. |
39 | 0 | 0 | 0 | 0 | 0 | 39 | |
| 25. | Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-kappa B | Chatchai Phoomak Kulthida Vaeteewoottacharn Kanlayanee Sawanyawisuth Wunchana Seubwai Chaisiri Wongkham Atit Silsirivanit Sopit Wongkham |
2016 |
SCIENTIFIC REPORTS (6.0), pp. |
28 | 0 | 0 | 0 | 0 | 0 | 28 | |
| 26. | Targeted delivery of 5-fluorouracil to cholangiocarcinoma cells using folic acid as a targeting agent | Nipaporn Ngernyuang Wunchana Seubwai Sakda Daduang Patcharee Boonsiri Temduang Limpaiboon Jureerut Daduang |
2016 |
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (60.0), pp. 411.0-415.0 |
25 | 0 | 0 | 0 | 0 | 0 | 25 | |
| 27. | Berberine Induces Cell Cycle Arrest in Cholangiocarcinoma Cell Lines via Inhibition of NF-kappa B and STAT3 Pathways | Nattapong Puthdee Wunchana Seubwai Kulthida Vaeteewoottacharn Thidarut Boonmars Ubon Cha'on Chatchai Phoomak Sopit Wongkham |
2017 |
BIOLOGICAL & PHARMACEUTICAL BULLETIN 6.0 (40.0), pp. 751.0-757.0 |
35 | 0 | 0 | 0 | 0 | 0 | 35 | |
| 28. | High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation | Chatchai Phoomak Kulthida Vaeteewoottacharn Atit Silsirivanit Charupong Saengboonmee Wunchana Seubwai Kanlayanee Sawanyawisuth Chaisiri Wongkham Sopit Wongkham |
2017 |
SCIENTIFIC REPORTS (7.0), pp. |
76 | 0 | 0 | 0 | 0 | 0 | 76 | |
| 29. | Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-kappa B | Charupong Saengboonmee Wunchana Seubwai Ubon Cha'on Kanlayanee Sawanyawisuth Sopit Wongkham Chaisiri Wongkham |
2017 |
ANTICANCER RESEARCH 1.0 (37.0), pp. 115.0-123.0 |
63 | 0 | 0 | 0 | 0 | 0 | 63 | |
| 30. | Overexpression of lactate dehydrogenase A in cholangiocarcinoma is correlated with poor prognosis | Unchalee Thonsri Wunchana Seubwai Sakda Waraasawapati Kanlayanee Sawanyawisuth Kulthida Vaeteewoottacharn Thidarat Boonmars Ubon Cha'on |
2017 |
HISTOLOGY AND HISTOPATHOLOGY 5.0 (32.0), pp. 503.0-510.0 |
37 | 0 | 0 | 0 | 0 | 0 | 37 | |
| 31. | Targeting hexokinase II as a possible therapy for cholangiocarcinoma | Ubonrat Thamrongwaranggoon Wunchana Seubwai Chatchai Phoomak Sakkarn Sangkhamanon Ubon Cha'on Thidarat Boonmars Sopit Wongkham |
2017 |
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 2.0 (484.0), pp. 409.0-415.0 |
32 | 0 | 0 | 0 | 0 | 0 | 32 | |
| 32. | Upregulation of CD147 Promotes Metastasis of Cholangiocarcinoma by Modulating the Epithelial-to-Mesenchymal Transitional Process | Paweena Dana Ryusho Kariya Kulthida Vaeteewoottacharn Kanlayanee Sawanyawisuth Wunchana Seubwai Kouki Matsuda Seiji Okada Sopit Wongkham |
2017 |
ONCOLOGY RESEARCH 7.0 (25.0), pp. 1047.0-1059.0 |
20 | 0 | 0 | 0 | 0 | 0 | 20 | |
| 33. | Activation of Vimentin Is Critical to Promote a Metastatic Potential of Cholangiocarcinoma Cells | Waraporn Saentaweesuk Norie Araki Kulthida Vaeteewoottacharn Atit Silsirivanit Wunchana Seubwai Chutima Talabnin Kanha Muisuk Banchob Sripa Sopit Wongkham Seiji Okada Chaisiri Wongkham |
2018 |
ONCOLOGY RESEARCH 4.0 (26.0), pp. 605.0-616.0 |
13 | 0 | 0 | 0 | 0 | 0 | 13 | |
| 34. | ANTI-MALARIAL DRUGS ARTESUNATE AND CHLOROQUINE INDUCE CELL DEATH BY DIFFERENT MECHANISMS IN BILE DUCT CANCER CELL LINES | Diwakar Guragain Norie Araki Atit Silsinivanit Wunchana Seubwai Ubon Cha'on |
2018 |
ANTICANCER RESEARCH 3.0 (38.0), pp. 1830.0-1830.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 35. | Artesunate and chloroquine induce cytotoxic activity on cholangiocarcinoma cells via different cell death mechanisms | Diwakar Guragain Wunchana Seubwai Daiki Kobayashi Atit Silsinivanit Kulthida Vaeteewoottacharn Kanlayanee Sawanyawisuth Chaisiri Wongkham Sopit Wongkham Norie Araki Ubon Cha'on |
2018 |
CELLULAR AND MOLECULAR BIOLOGY 10.0 (64.0), pp. 113.0-118.0 |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 36. | Chloroquine reduces metastases of cholangiocarcinoma cells in lungs by tail vein assay of cancer metastasis | Kanokwan Nahok Diwakar Guragain Sopit Wongkham Wunchana Seubwai Ubon Cha'on |
2018 |
CANCER SCIENCE (109.0), pp. 1016.0-1016.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 37. | Potential prediction of patient survival and chemotherapeutic sensitivity in cholangiocarcinoma using FTIR microspectroscopy | Molin Wongwattanakul Chariya Hahnvajanawong Wunchana Seubwai Chanvit Leelayuwat Temduang Limpaiboon Patcharee Jearanaikoon |
2018 |
JOURNAL OF MOLECULAR STRUCTURE (1166.0), pp. 416.0-421.0 |
5 | 0 | 0 | 0 | 0 | 0 | 5 | |
| 38. | Blocking of methionine aminopeptidase-2 by TNP-470 induces apoptosis and increases chemosensitivity of cholangiocarcinoma | Sonexai Kidoikhammouan Wunchana Seubwai Atit Silsirivanit Sopit Wongkham Kanlayanee Sawanyawisuth Chaisiri Wongkham |
2019 |
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS 1.0 (15.0), pp. 148.0-152.0 |
5 | 0 | 0 | 0 | 0 | 0 | 5 | |
| 39. | Overexpression of HexCer and LacCer containing 2-hydroxylated fatty acids in cholangiocarcinoma and the association of the increase of LacCer (d18:1-h23:0) with shorter survival of the patients | Atit Silsirivanit Chatchai Phoomak Karuntarat Teeravirote Sasiprapa Wattanavises Wunchana Seubwai Charupong Saengboonmee Zhaoqi Zhan Jin-ichi Inokuchi Akemi Suzuki Sopit Wongkham |
2019 |
GLYCOCONJUGATE JOURNAL 2.0 (36.0), pp. 103.0-111.0 |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 40. | Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma | Surangkana Sanmai Tanakorn Proungvitaya Temduang Limpaiboon Daraporn Chua-On Wunchana Seubwai Sittiruk Roytrakul Sopit Wongkham Chaisiri Wongkham Ongart Somintara Sakkarn Sangkhamanon Siriporn Proungvitaya |
2019 |
ONCOLOGY LETTERS 6.0 (17.0), pp. 5275.0-5282.0 |
11 | 0 | 0 | 0 | 0 | 0 | 11 | |
| 41. | Antitumor Effect of Shikonin, a PKM2 Inhibitor, in Cholangiocarcinoma Cell Lines | Unchalee Thonsri Wunchana Seubwai Sakda Waraasawapati Sopit Wongkham Thidarat Boonmars Ubon Cha'on Chaisiri Wongkham |
2020 |
ANTICANCER RESEARCH 9.0 (40.0), pp. 5115.0-5124.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 42. | Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient | Banchob Sripa Wunchana Seubwai Kulthida Vaeteewoottacharn Kanlayanee Sawanyawisuth Atit Silsirivanit Worasak Kaewkong Kanha Muisuk Paweena Dana Chatchai Phoomak Worachart Lert-itthiporn Vor Luvira Chawalit Pairojkul Bin T. Teh Sopit Wongkham Seiji Okada Yaovalux Chamgramol |
2020 |
HUMAN CELL 3.0 (33.0), pp. 695.0-708.0 |
31 | 0 | 0 | 0 | 0 | 0 | 31 | |
| 43. | Multi-serum glycobiomarkers improves the diagnosis and prognostic prediction of cholangiocarcinoma | Atit Silsirivanit Atsushi Matsuda Atsushi Kuno Chikayuki Tsuruno Yuta Uenoyama Wunchana Seubwai Kiyohiko Angata Karuntarat Teeravirote Chaisiri Wongkham Norie Araki Youichi Takahama Sopit Wongkham Hisashi Narimatsu |
2020 |
CLINICA CHIMICA ACTA (510.0), pp. 142.0-149.0 |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 44. | NF-kappa B and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells | Charupong Saengboonmee Chatchai Phoomak Suangson Supabphol Kyle R. Covington Oliver Hampton Chaisiri Wongkham Richard A. Gibbs Kazuo Umezawa Wunchana Seubwai Marie-Claude Gingras Sopit Wongkham |
2020 |
LIFE SCIENCES (262.0), pp. |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 45. | Aberrant GLUT1 Expression Is Associated With Carcinogenesis and Progression of Liver Fluke-associated Cholangiocarcinoma | Ubonrat Thamrongwaranggoon Sakkarn Sangkhamanon Wunchana Seubwai Paksiree Saranaruk U. B. O. N. CHA'ON Sopit Wongkham |
2021 |
IN VIVO 1.0 (35.0), pp. 267.0-274.0 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 46. | Association of Diabetes Mellitus and Cholangiocarcinoma: Update of Evidence and the Effects of Antidiabetic Medication | Charupong Saengboonmee Wunchana Seubwai Worachart Lert-Itthiporn Thanachai Sanlung Sopit Wongkham |
2021 |
CANADIAN JOURNAL OF DIABETES 3.0 (45.0), pp. 282.0-290.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 47. | Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma | Prin Sungwan Worachart Lert-itthiporn Atit Silsirivanit Nathakan Klinhom-on Seiji Okada Sopit Wongkham Wunchana Seubwai |
2021 |
PEERJ (9.0), pp. |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 48. | Cyclin A is upregulated by high glucose and a potential target for cholangiocarcinoma patients with diabetes mellitus | Charupong Saengboonmee Wunchana Seubwai Sakkarn Sangkhamanon Marutpong Detarya Kanlayanee Sawanyawisuth Atit Silsirivanit Sopit Wongkham |
2021 |
CANCER SCIENCE (112.0), pp. 540.0-540.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 49. | FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients | Nathakan Klinhom-on Wunchana Seubwai Kanlayanee Sawanyawisuth Worachart Lert-itthiporn Sakda Waraasawapati Marutpong Detarya Sopit Wongkham |
2021 |
HELIYON 4.0 (7.0), pp. |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 50. | High glucose: an emerging association between diabetes mellitus and cancer progression | Suangson Supabphol Wunchana Seubwai Sopit Wongkham Charupong Saengboonmee |
2021 |
JOURNAL OF MOLECULAR MEDICINE-JMM 9.0 (99.0), pp. 1175.0-1193.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 51. | High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus | Charupong Saengboonmee Marutpong Detarya Sakkarn Sangkhamanon Kanlayanee Sawanyawisuth Wunchana Seubwai Sopit Wongkham |
2021 |
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 52. | High glucose-ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8 | Unchalee Thonsri Sopit Wongkham Chaisiri Wongkham Shinjiro Hino Mitsuyoshi Nakao Sittiruk Roytrakul Tomoaki Koga Wunchana Seubwai |
2021 |
CANCER SCIENCE 1.0 (112.0), pp. 254.0-264.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 53. | High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinoma | Marutpong Detarya Salak Thaenkaew Wunchana Seubwai Somsiri Indramanee Chatchai Phoomak Charupong Saengboonmee Sopit Wongkham Chaisiri Wongkham |
2021 |
LIFE SCIENCES (271.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 54. | Homophilic Interaction of CD147 Promotes IL-6-Mediated Cholangiocarcinoma Invasion via the NF-kappa B-Dependent Pathway | Paweena Dana Ryusho Kariya Worachart Lert-itthiporn Wunchana Seubwai Saowaluk Saisomboon Chaisiri Wongkham Seiji Okada Sopit Wongkham Kulthida Vaeteewoottacharn |
2021 |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 24.0 (22.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 55. | Kallikrein-11, in Association with Coiled-Coil Domain Containing 25, as a Potential Prognostic Marker for Cholangiocarcinoma with Lymph Node Metastasis | Saeranee Siriphak Ravinnipa Chanakankun Tanakorn Proungvitaya Sittiruk Roytrakul Doungdean Tummanatsakun Wunchana Seubwai Molin Wongwattanakul Siriporn Proungvitaya |
2021 |
MOLECULES 11.0 (26.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Natural Products for Prevention and Treatment of Cholangiocarcinoma | Chariya Hahnvajanawong Khon Kaen University - Natural Products Chemistry Research Unit Wunchana Seubwai Faculty of Medicine - Department of Forensic Medicine Thidarut Boonmars Faculty of Medicine - Department of Parasitology Kulthida Vaeteewoottacharn Faculty of Medicine - Department of Biochemistry |
2012 |
Srinagarind Medical Journal (27), pp. 371-380 |
|
| 2. | Enhanced antitumor activity of DHMEQ, a NF-κB Inhibitor, on Cholangiocarcinoma Cell Lines by Decreasing the Expression of ABC Transporters | Wunchana Seubwai Kulthida Vaeteewoottacharn Kazuo Umezawa Seiji Okada Sopit Wongkham |
2013 |
Srinagarind Medical Journal (28 No 4), pp. 171 |
|
| 3. | Determining the Manner of Death Using Fourier Transform Infrared Microspectroscopy: A Preliminary Study | Wunchana Seubwai Wirut Khunkitti Maneewan Tanratanavijit Thitichai Wiangsimma Molin Wongwattanakul Patcharee Jearanaikoon Sirinart Srichan |
2013 |
Srinagarind Medical Journal (28 No 4), pp. 203 |
|
| 4. | Application of Molecular Biology Techniques on Forensic Sciences | Wunchana Seubwai Wirut Khunkitti |
2014 |
Srinagarind Medical Journal (29 No 3), pp. 321-326 |
|
| 5. | Potential Glyco-Biomarkers Identified Suicide Victims | Wunchana Seubwai Wirut Khunkitti Maneewan Tanratanavijit Thitichai Wiangsimma Sopit Wongkham |
2014 |
Srinagarind Medical Journal (29 No 4), pp. 68 |
|
| 6. | Diabetogenic Glucose Enhances Aggressive Activities of Cholangiocarcinoma Cell Lines | Charupong Saengboonmee Wunchana Seubwai Sopit Wongkham |
2014 |
Srinagarind Medical Journal (29 No 4), pp. 65 |
|
| 7. | Tumor Glycolysis as a Target for Cancer Diagnosis and Therapy | Wunchana Seubwai | 2015 |
Srinagarind Medical Journal (30 No 2), pp. 184-192 |
| Title | Authors | NRIIS type | Year | NRIIS Scholarship | ||
|---|---|---|---|---|---|---|
| 1. | การรักษาแบบมุ่งเป้าสำหรับผู้ป่วยมะเร็งท่อน้ำดี |
ศ.ดร. โสพิศ วงศ์คำ นายธนกร ปรุงวิทยา รศ.ดร. ชัยศิริ วงศ์คำ ศ.ดร.สพญ. ธิดารัตน์ บุญมาศ ผศ.ดร. อาทิตย์ ศิลป์ศิริวานิชย์ ศ.ดร. เต็มดวง ลิ้มไพบูลย์ ผศ.ดร.พญ. กุลธิดา เวทีวุฒาจารย์ รศ.ดร. ศิริพร ปรุงวิทยา ผศ.ดร. วันชนะ สืบไวย |
ชุดโครงการวิจัย | 2557 | ทุนงบประมาณแผ่นดินประจำปี 2557 | |
| 2. | ตัวยับยั้งวิถี NF-kB เพื่อการรักษามะเร็งท่อน้ำดี |
รศ.ดร. ชัยศิริ วงศ์คำ ผศ.ดร.พญ. กุลธิดา เวทีวุฒาจารย์ ศ.ดร. โสพิศ วงศ์คำ ผศ.ดร. วันชนะ สืบไวย ศ.ดร.สพญ. ธิดารัตน์ บุญมาศ |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2557 | ทุนงบประมาณแผ่นดินประจำปี 2557 | |
| 3. | ตัวยับยั้งวิถีไกลโคไลซิสในกระบวนการก่อและพัฒนามะเร็ง: การประยุกต์ใช้เพื่อการรักษามะเร็งท่อน้ำดี |
ผศ.ดร. วันชนะ สืบไวย ศ.ดร. โสพิศ วงศ์คำ ผศ.ดร.พญ. กุลธิดา เวทีวุฒาจารย์ |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2557 | ทุนงบประมาณแผ่นดินประจำปี 2557 | |
| 4. | การวิเคราะห์ลักษณะของเซลล์มะเร็งท่อน้ำดี ที่ดื้อต่อยา gemcitabine และการทำให้เซลล์ที่ดื้อต่อยา gemcitabine กลับไปไวต่อยาโดยใช้ caged xanthones และ rhinacanthin-C |
ผศ.ดร. ศิริมาศ กาญจนวาศ นางจริยา หาญวจนวงศ์ ศ.ดร. วิจิตรา ทัศนียกุล รศ.ดร. นิษณา นามวาท ผศ.ดร. วันชนะ สืบไวย ผศ.ดร.นพ. สุวิน ว่องวัจนะ ศ.ดร. วิชัย ริ้วตระกูล |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2558 | ทุนงบประมาณแผ่นดินประจำปี 2558 | |
| 5. | ผลของ caged xanthone ชนิด forbesione ที่แยกได้จากต้น Garcinia hanburyi ในการยับยั้งมะเร็งท่อน้ำดีและฤทธิ์ความเป็นพิษในหนูแฮมสเตอร์ |
นางจริยา หาญวจนวงศ์ ผศ.ดร.พญ. กุลธิดา เวทีวุฒาจารย์ ศ.ดร.สพญ. ธิดารัตน์ บุญมาศ ผศ.ดร. วันชนะ สืบไวย ศ.ดร. วิชัย ริ้วตระกูล |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2558 | ทุนงบประมาณแผ่นดินประจำปี 2558 | |
| 6. | การค้นหาโมเลกุลเป้าหมายเพื่อการรักษามะเร็งท่อน้ำดี |
ศ.ดร. โสพิศ วงศ์คำ ผศ.ดร. กัลยาณี สวรรยาวิสุทธิ์ ผศ.ดร. วันชนะ สืบไวย ผศ.ดร.พญ. กุลธิดา เวทีวุฒาจารย์ ผศ.ดร. อุบล ชาอ่อน รศ.ดร. ศิริพร ปรุงวิทยา |
ชุดโครงการวิจัย | 2559 | ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2) | |
| 7. | การใช้กลูโคสและเมตาบอลิซึมของกลูโคส เพื่อเป็นเป้าหมายในการรักษามะเร็งท่อน้ำดี |
ผศ.ดร. วันชนะ สืบไวย ศ.ดร. โสพิศ วงศ์คำ ผศ.ดร. อุบล ชาอ่อน |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2559 | ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2) | |
| 8. | การใช้รูปแบบลายพิมพ์อินฟราเรดสเปคตรัมเพื่อเป็นตัวบ่งชี้ชีวภาพรุปแบบใหม่ ในการตรวจวินิจฉัยและติดตามการรักษามะเร็งท่อน้ำดี |
รศ.ดร. พัชรี เจียรนัยกูร ผศ.ดร. วันชนะ สืบไวย นางนิชาดา เจียรนัยกูร รศ.ดร. ชัยศิริ วงศ์คำ นายชวลิต ไพโรจน์กุล นางสาวเยาวลักษณ์ ฉ่ำกระมล |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2559 | ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2) | |
| 9. | ยาฆ่าพยาธิและยารักษาเบาหวานเพื่อการรักษามะเร็งท่อน้ำดี |
ผศ.ดร. อุบล ชาอ่อน ผศ.ดร. วันชนะ สืบไวย ผศ.ดร. กัลยาณี สวรรยาวิสุทธิ์ ผศ.ดร.พญ. กุลธิดา เวทีวุฒาจารย์ รศ.ดร. ชัยศิริ วงศ์คำ |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2559 | ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2) | |
| 10. | การใช้รูปแบบลายพิมพ์อินฟราเรดสเปคตรัมเพื่อบ่งชี้แนวใหม่ในการตรวจวินิจฉัยและติดตามการรักษามะเร็งท่อน้ำดี |
รศ.ดร. พัชรี เจียรนัยกูร นายชวลิต ไพโรจน์กุล นางสาวเยาวลักษณ์ ฉ่ำกระมล รศ.ดร. ชัยศิริ วงศ์คำ ผศ.ดร. วันชนะ สืบไวย นางนิชาดา เจียรนัยกูร |
โครงการ | 2560 | ทุนงบประมาณแผ่นดินประจำปี 2560 | |
| 11. | การค้นหาโมเลกุลเป้าหมายเพื่อการรักษามะเร็งท่อน้ำดีการค้นหาโมเลกุลเป้าหมายเพื่อการรักษามะเร็งท่อน้ำดี |
ศ.ดร. โสพิศ วงศ์คำ ผศ.ดร. กัลยาณี สวรรยาวิสุทธิ์ รศ.ดร. ศิริพร ปรุงวิทยา ผศ.ดร.พญ. กุลธิดา เวทีวุฒาจารย์ ผศ.ดร. อาทิตย์ ศิลป์ศิริวานิชย์ ผศ.ดร. วันชนะ สืบไวย นายธนกร ปรุงวิทยา นางสาวภัทรินทร์ โพธิพันธุ์ ดร. ปวีณา ดานะ นางสาวปิยะนาฏ บุญเนตร นางสาววรพร แสนทวีสุข นางสาวอัญชลี ต้นศรี นางสาวอุบลรัตน์ ธำรงวรางกูรนายมารุตพงศ์ นางสาวสมสิริ อินทรมณี ดร. จารุพงษ์ แสงบุญมี นายฉัตรชัย ภู่มาก ผศ.ดร. อุบล ชาอ่อน รศ.ดร. ชัยศิริ วงศ์คำ ศ.ดร. เต็มดวง ลิ้มไพบูลย์ |
ชุดโครงการวิจัย | 2561 | ทุนงบประมาณแผ่นดินประจำปี 2561 (งบบูรณาการวิจัยและนวัตกรรม) | |
| 12. | การใช้กลูโคส และเมตาบอลิซึมของกลูโคส เพื่อเป็นเป้าหมายในการรักษามะเร็งท่อน้ำดี |
ผศ.ดร. วันชนะ สืบไวย นางสาวอัญชลี ต้นศรี นางสาวอุบลรัตน์ ธำรงวรางกูร ศ.ดร. โสพิศ วงศ์คำ ผศ.ดร. อุบล ชาอ่อน |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2561 | ทุนงบประมาณแผ่นดินประจำปี 2561 (งบบูรณาการวิจัยและนวัตกรรม) | |
| 13. | การพัฒนาการตรวจวินิจฉัยและการรักษามะเร็งท่อน้ำดีโดยโมเลกุลเป้าหมายแบบองค์รวม |
รศ.ดร. ศิริพร ปรุงวิทยา ศ.ดร. โสพิศ วงศ์คำ รศ.ดร. ชัยศิริ วงศ์คำ ศ.ดร. เต็มดวง ลิ้มไพบูลย์ ผศ.ดร.พญ. กุลธิดา เวทีวุฒาจารย์ ผศ.ดร. กัลยาณี สวรรยาวิสุทธิ์ ผศ.ดร. วันชนะ สืบไวย ผศ.ดร. อาทิตย์ ศิลป์ศิริวานิชย์ ผศ.ดร. อุบล ชาอ่อน นายธนกร ปรุงวิทยา ดร. สิทธิรักษ์ รอยตระกูล ดร. ปวีณา ดานะ นายฉัตรชัย ภู่มาก นางสาวภัคสิรี สรณารักษ์ น.ส. เสาวลักษณ์ สายสมบูรณ์ นายจิตรภาณุ มณีสาร นางสาววรพร แสนทวีสุข นางสาวศศิประภา วัฒนวิเศษ นางสาวกรัณฑรัตน์ ธีรวิโรจน์ นางสาวอรสา พนาวัน |
ชุดโครงการวิจัย | 2562 | ทุนงบประมาณแผ่นดินประจำปี 2562 (งบบูรณาการวิจัยและนวัตกรรม) | |
| 14. | การพัฒนาวิธีวัดระดับบิริรูบินด้วยค่าความเหลืองของส่วนตาขาวในผู้ป่วยมะเร็งท่อน้ำดีโดยแอพพลิเคชั่นบนมือถือ |
นพ. วร์ ลุวีระ ศ.ดร. โสพิศ วงศ์คำ ผศ.ดร. วันชนะ สืบไวย ดร. จารุพงษ์ แสงบุญมี |
โครงการ | 2562 | ทุนงบประมาณแผ่นดินประจำปี 2562 (งบบูรณาการวิจัยและนวัตกรรม) | |
| 15. | ชุดตรวจตัวบ่งชี้ชีวภาพในเลือดแบบองค์รวมเพื่อวินิจฉัยและพยากรณ์โรค มะเร็งท่อน้ำดี |
ศ.ดร. โสพิศ วงศ์คำ รศ.ดร. ชัยศิริ วงศ์คำ รศ.ดร. ศิริพร ปรุงวิทยา ผศ.ดร. กัลยาณี สวรรยาวิสุทธิ์ ผศ.ดร. วันชนะ สืบไวย ผศ.ดร. อาทิตย์ ศิลป์ศิริวานิชย์ นายธนกร ปรุงวิทยา นางสาวศศิประภา วัฒนวิเศษ นางสาวกรัณฑรัตน์ ธีรวิโรจน์ |
โครงการ | 2562 | ทุนงบประมาณแผ่นดินประจำปี 2562 (งบบูรณาการวิจัยและนวัตกรรม) |